bms Advances European Strategy with Preparation for Production in Germany

In September 2025, Dr. Lisa Hejun, Founder and Shareholder of bms, visited Leipzig, Germany—home to the nation's largest biolake—as part of bms's strategic expansion into the European market.

The state of Sachsen, known for its strong governmental support for biotechnology and medical innovation, invited Dr. Hejun to explore local R&D and production opportunities.

During the visit, arranged by the Sachsen state government, Dr. Hejun toured the renowned Fraunhofer Institute for Cell Therapy and Gene Research,

visited Vita 34—Europe's leading private cord blood bank—and participated in an innovation-focused conference. She also held productive dialogues with key government representatives.

This visit represents a major milestone in bms's strategic plan to establish a production and innovation presence in the European market.